PandyaB.K., MarshallL., AhmadR.Postoperative exit-site infection and factors affecting it (Letter).Perit Dial Int2001; 21: 418–19.
2.
ThodisE., BhaskaranS., PasadakisP., BargmanJ.M., VasS.I., OreopoulosD.G.Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site.Perit Dial Int1998; 18: 261–70.
3.
BernardiniJ., PirainoB., HolleyJ., JohnstonJ.R., LutesR.A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.Am J Kidney Dis1996; 27: 695–700.
4.
CaseyM., TaylorJ., ClinardP., GrahamA., MauckV., SpainhourL.Application of mupirocin cream at the catheter exit site reduces exit-site infections and peritonitis in peritoneal dialysis patients.Perit Dial Int2000; 20: 566–8.
5.
RitzauJ., HoffmanR.M., TzamaloukasA.H.Effect of preventing Staphylococcus aureus carriage on rates of peritoneal catheter-related staphylococcal infections.Perit Dial Int2001; 21: 471–9.
6.
PirainoB.Is it possible to decrease the rate of Staphylococcus aureus peritonitis?Perit Dial Int1996; 16: 446–7.
7.
VasS.I., ConlyJ., BargmanJ.M., OreopoulosD.G.Resistance to mupirocin: no indication of it to date while using mupirocin ointment for prevention of Staphylococcus aureus exit-site infections in peritoneal dialysis patients.Perit Dial Int1999; 19: 313–14.
